School of Medicine


Showing 141-150 of 266 Results

  • Mary Kane Goldstein

    Mary Kane Goldstein

    Professor of Health Policy, Emerita

    Current Research and Scholarly InterestsHealth services research in primary care and geriatrics: developing, implementing, and evaluating methods for clinical quality improvement. Current work includes applying health information technology to quality improvement through clinical decision support (CDS) integrated with electronic health records; encoding clinical knowledge into computable formats in automated knowledge bases; natural language processing of free text in electronic health records; analyzing multiple comorbidities

  • Andrea Goldstein-Piekarski

    Andrea Goldstein-Piekarski

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)

    BioDr. Goldstein-Piekarski directs the Computational Psychiatry, Neuroscience, and Sleep Laboratory (CoPsyN Sleep Lab) as an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and PI within the Sierra-Pacific Mental Illness Research, Education and Clinical Center (MIRECC) at the Palo Alto VA. She received her PhD in 2014 at the University of California, Berkeley where she studied the consequences of sleep on emotional brain function. She then completed a Postdoctoral fellowship at Stanford focusing on understanding the brain basis of anxiety and depression.

    As the director of the CoPsyN Sleep Lab she is developing a translational, interdisciplinary research program that combines human neuroimaging, high-density EEG sleep recording, and computational modeling to understand the neural mechanisms through which sleep disruption contributes to affective disorders, particularly depression, across the lifespan. The ultimate goals of this research are to (1) develop mechanistically-informed interventions that directly target aspects of sleep and brain function to prevent and treat affective disorders and (2) identify novel biomarkers which can identify which individuals are most likely to experience improved mood following targeted sleep interventions.

    This work is currently supported by The KLS Foundation, a R01 from National Institute of Mental Health, and a R61 from the National Institute of Mental Health.

  • Bruna Gomes

    Bruna Gomes

    Assistant Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Biomedical Data Science

    Current Research and Scholarly InterestsThe increasing availability of very large datasets, along with recent advances in deep learning based tools for automatic extraction of cardiac traits, has led to the discovery of further common variants associated with cardiac disease. However, the genetic underpinnings of valvular heart disease remains understudied. I am interested in developing deep learning techniques to automatically extract cardiac flow information to facilitate genome-wide association studies of cardiac flow traits.

  • Pedro Martins Gomes de Oliveira, MD

    Pedro Martins Gomes de Oliveira, MD

    Clinical Assistant Professor, Otolaryngology (Head and Neck Surgery)

    BioDr. Gomes de Oliveira is an oral maxillofacial surgeon, head and neck surgeon, and sleep specialist with the Stanford Health Care Sleep Surgery Program. He is also a clinical assistant professor in the Department of Otolaryngology – Head and Neck Surgery, Division of Sleep Surgery at Stanford University School of Medicine.

    Dr. Gomes de Oliveira specializes in orthognathic (jaw) and sleep surgery. He treats simple to complex cases of obstructive sleep apnea, creating personalized, effective care plans for each of his patients.

    Dr. Gomes de Oliveira studies new treatments and best practices in jaw, sleep, and facial surgeries. He has analyzed psychiatric and cardiovascular outcomes in sleep surgery patients and researched sports-related facial fractures. Dr. Gomes de Oliveira has a background as a clinical and scientific researcher for the NOVA Clinical Research Unit in Lisbon, Portugal.

    National and international peer-reviewed journals, including the Journal of Cranio-Maxillo-Facial Surgery, have published Dr. Gomes de Oliveira’s work. He has been invited to share his findings at national and global meetings, including for the American Academy of Otolaryngology and the European Association for Cranio Maxillo Facial Surgery (EACMFS).

    Dr. Gomes de Oliveira is a member of EACMFS and the Spanish Society of Oral and Maxillofacial and Head and Neck Surgery. He is also a board member of the Portuguese Society of Maxillofacial Surgery.

  • Natalia Gomez-Ospina

    Natalia Gomez-Ospina

    Assistant Professor of Pediatrics (Genetics)

    Current Research and Scholarly Interests1. Genome Editing and HSPC-Based Therapeutics

    Dr. Gomez-Ospina’s research focuses on developing autologous hematopoietic stem and progenitor cell therapies using CRISPR/Cas9-mediated genome editing. Her work includes targeted integration of therapeutic transgenes into genomic safe-harbor loci, optimization of editing efficiency and safety, and development of transplantation and conditioning strategies that preserve long-term engraftment. A major goal is to create reusable, mutation-agnostic therapeutic platforms that can be adapted across diseases. Her translational work also extends to GMP manufacturing, analytical development, and IND-enabling studies needed to move genome-edited HSPC products toward clinical trials.

    2. Neurometabolic and Neurodegenerative Disease Therapeutics

    A major area of interest is the development of definitive therapies for lysosomal storage disorders and other neurogenetic diseases, including MPS I, Gaucher disease, Krabbe disease, progranulin deficiency, and Friedreich’s ataxia. Her laboratory investigates how hematopoietic-derived cells can deliver therapeutic proteins to peripheral tissues and the central nervous system. This includes strategies to enhance microglial replacement, improve CNS engraftment, and harness myeloid cells as therapeutic vehicles. The broader objective is to establish cell-based approaches capable of treating both inherited neurometabolic disorders and more common neurodegenerative diseases.

    3. Rare Disease Genetics, Functional Genomics, and Lysosome Biology

    Dr. Gomez-Ospina also studies the molecular basis of rare and undiagnosed genetic disorders. Through clinical genetics, international collaborations, and the NIH Undiagnosed Diseases Network, her work contributes to novel disease-gene discovery, functional validation of candidate variants, and definition of genotype–phenotype relationships. Her laboratory also investigates lysosomal biology and develops systems-level approaches, including the Lysosome Disease Atlas, to connect lysosome-associated genes with cellular function and human phenotypes. These efforts aim to improve diagnosis while identifying new disease mechanisms and therapeutic opportunities.

    For more information go to our website:

    https://www.gomezospina.com/